Literature DB >> 4907727

General inhibition of Escherichia coli macromolecular synthesis by high multiplicites of bacteriophage phiX174.

A B Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4907727     DOI： 10.1016/0022-2836(70)90341-4

Source DB:  PubMed          Journal:  J Mol Biol        ISSN： 0022-2836            Impact factor:   5.469


× No keyword cloud information.
  9 in total

1.  Process of infection with bacteriophage phiX174. XXXVII. RNA metabolism in phiX174-infected cells.

Authors:  J B Clements; R L Sinsheimer
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

2.  A simplified method for preparing sucrose gradients.

Authors:  A B Stone
Journal:  Biochem J       Date:  1974-01       Impact factor: 3.857

3.  Histidine starvation and completion of the bacterial deoxyribonucleic acid replication cycle.

Authors:  A B Stone
Journal:  Mol Gen Genet       Date:  1972

4.  Regulation of cell division in a temperature-sensitive division mutant of Escherichia coli.

Authors:  A B Stone
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

5.  Vegetative DNA of temperate coliphage P2.

Authors:  B H Lindqvist
Journal:  Mol Gen Genet       Date:  1971

6.  Effect of bacteriophage phi X174 infection on the conformation of Escherichia coli DNA.

Authors:  S K Pal; R K Poddar
Journal:  Mol Gen Genet       Date:  1982

7.  The cytogenetic, proliferative and viability effects of four bacteriophages on human lymphocytes.

Authors:  S L Wenger; J H Turner; J C Petricciani
Journal:  In Vitro       Date:  1978-06

8.  Superinfection in bacteriophage S13 and determination of the number of bacteriophage particles which can function in an infected cell.

Authors:  E S Tessman; M T Borrás; I L Sun
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

9.  Origin and metabolic properties of the RNA species formed during the replication cycle of virus 2C.

Authors:  C Cocito
Journal:  J Virol       Date:  1974-12       Impact factor: 5.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.